METTLER TOLEDO INTERNATIONAL INC/ MTD
NYSE · XNYS · stock · Laboratory Analytical Instruments
Chart by TradingView
5/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $4.0B | $869.2M | $2.4B | $848.6M | -$23.6M |
| 2024 | $3.9B | $863.1M | $2.3B | $864.4M | -$126.9M |
| 2023 | $3.8B | $788.8M | $2.2B | $860.6M | -$149.9M |
| 2022 | $3.9B | $872.5M | $2.3B | $737.8M | $24.8M |
| 2021 | $3.7B | $769.0M | $2.2B | $801.2M | $171.4M |
| 2020 | $3.1B | $602.7M | $1.8B | $632.2M | $282.7M |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0001037646 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.